This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.
本发明涉及新型化合物和药物组合物,其中包括本发明化合物可作为Rho相关蛋白激酶(ROCK)的调节剂,例如ROCK1和/或ROCK2
抑制剂。本发明还考虑了采用本发明化合物的治疗方法。本发明的化合物可用于治疗 ROCK 介导的疾病。